State Street’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,098,806
| Closed | -$48.7M | – | 4425 |
|
|
2024
Q1 | $48.7M | Buy |
3,098,806
+627,993
| +25% | +$9.67M | ﹤0.01% | 1743 |
|
|
2023
Q4 | $39.9M | Buy |
2,470,813
+159,695
| +7% | +$2.04M | ﹤0.01% | 1834 |
|
|
2023
Q3 | $29.4M | Sell |
2,311,118
-858,377
| -27% | -$11.8M | ﹤0.01% | 1933 |
|
|
2023
Q2 | $44.6M | Sell |
3,169,495
-152,655
| -5% | -$2.18M | ﹤0.01% | 1741 |
|
|
2023
Q1 | $51.3M | Sell |
3,322,150
-125,874
| -4% | -$2.1M | ﹤0.01% | 1634 |
|
|
2022
Q4 | $56.5M | Buy |
3,448,024
+228,693
| +7% | +$3.72M | ﹤0.01% | 1540 |
|
|
2022
Q3 | $59.6M | Sell |
3,219,331
-711,586
| -18% | -$11.2M | ﹤0.01% | 1477 |
|
|
2022
Q2 | $51.7M | Sell |
3,930,917
-1,807,853
| -32% | -$20M | ﹤0.01% | 1611 |
|
|
2022
Q1 | $53.2M | Sell |
5,738,770
-740,052
| -11% | -$6.29M | ﹤0.01% | 1718 |
|
|
2021
Q4 | $63.3M | Buy |
6,478,822
+4,557,902
| +237% | +$85.7M | ﹤0.01% | 1650 |
|
|
2021
Q3 | $65.3M | Sell |
1,920,920
-129,914
| -6% | -$4.15M | ﹤0.01% | 1605 |
|
|
2021
Q2 | $75.1M | Buy |
2,050,834
+191,797
| +10% | +$7.43M | ﹤0.01% | 1535 |
|
|
2021
Q1 | $83.4M | Buy |
1,859,037
+24,962
| +1% | +$1.16M | ﹤0.01% | 1373 |
|
|
2020
Q4 | $105M | Buy |
1,834,075
+64,913
| +4% | +$3.85M | 0.01% | 1114 |
|
|
2020
Q3 | $90.8M | Buy |
1,769,162
+48,524
| +3% | +$2.38M | 0.01% | 1033 |
|
|
2020
Q2 | $103M | Buy |
1,720,638
+649,251
| +61% | +$34.7M | 0.01% | 941 |
|
|
2020
Q1 | $44.1M | Buy |
1,071,387
+36,143
| +3% | +$2.01M | ﹤0.01% | 1336 |
|
|
2019
Q4 | $64.4M | Buy |
1,035,244
+281,008
| +37% | +$13.4M | ﹤0.01% | 1346 |
|
|
2019
Q3 | $25.6M | Buy |
754,236
+124,005
| +20% | +$3.67M | ﹤0.01% | 1900 |
|
|
2019
Q2 | $14.2M | Buy |
630,231
+7,610
| +1% | +$178K | ﹤0.01% | 2311 |
|
|
2019
Q1 | $14.5M | Buy |
622,621
+33,468
| +6% | +$876K | ﹤0.01% | 2267 |
|
|
2018
Q4 | $12.4M | Buy |
589,153
+3,193
| +0.5% | +$78.5K | ﹤0.01% | 2313 |
|
|
2018
Q3 | $22.7M | Buy |
585,960
+438,630
| +298% | +$16.2M | ﹤0.01% | 2091 |
|
|
2018
Q2 | $5.8M | Buy |
147,330
+23,589
| +19% | +$694K | ﹤0.01% | 2796 |
|
|
2018
Q1 | $2.48M | Buy |
123,741
+55,060
| +80% | +$1.39M | ﹤0.01% | 3076 |
|
|
2017
Q4 | $1.56M | Buy |
+68,681
| New | +$1.34M | ﹤0.01% | 3258 |
|
Other funds holding DCPH
State Street's DCPH Position: Q2 2024 in Review
State Street sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 3,098,806 shares — an estimated $48.7M sold.
State Street first reported a position in DCPH in Q4 2017 and held it in 26 quarters. The position peaked at $105M in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- State Street reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- State Street sold 3,098,806 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $48.7M.
- State Street first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 26 quarters.
- State Street's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $105M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.